China Pharmaceutical Filtration Market Research Report, 2030

The early 2000s marked the start of China's large-scale production of pharmaceutical filters, which coincided with the 10th and 11th Five-Year Plans' more comprehensive drive to modernize pharmaceutical manufacturing. The majority of high-performance filtration systems were imported prior to this time. But local filter production increased as the country sought GMP compliance in accordance with international norms and domestic pharmaceutical production rose. Chinese companies like Trueline, Hangzhou Cobetter, and Membrane Solutions had become major providers by the middle of the 2010s. This expansion was heavily influenced by government initiatives like "Made in China 2025" and "Healthy China 2030," which promoted import substitution and innovation in medical technology. The National Medical Products Administration (NMPA) also began to enforce stricter GMP standards, increasing the demand for sterile and validated filtration technologies. Filter companies that made investments in R&D and quality certifications were given subsidies and tax breaks. Filters are widely used in biologics, especially in the production of monoclonal antibodies, vaccines, and recombinant proteins, in terms of their key applications. The development of Traditional Chinese Medicines (TCMs) necessitated unique filtration methods for the removal of particulates, pyrogens, and microbial pollutants from complex plant-based solutions, particularly for injectable TCMs that demand high purity. Chinese pharmaceutical filters are technically in line with international standards like USP, ISO 13485, and ASTM. Nevertheless, the design and performance validation are also influenced by national standards, such as those from the Chinese Pharmacopoeia, which frequently place emphasis on robustness, cost-efficiency, and compatibility with various pharmaceutical preparations. Regulatory harmonization is still a significant challenge. Discrepancies between Chinese and Western validation protocols persist, particularly in the areas of filter integrity testing, sterilization validation, and extractables/leachables data, even if progress has been made. According to the research report, "China Pharmaceutical Filtration Market Research Report, 2030," published by Actual Market Research, the China Pharmaceutical Filtration market is anticipated to add to more than USD 570 Million by 2025–30. Dominant application areas include biologics manufacturing, particularly monoclonal antibodies, recombinant proteins, and cell therapies, as well as sterile injectable drugs and vaccine production, which experienced exponential demand during and after the COVID-19 pandemic. Government-backed R&D investment is a significant driver of expansion. The Chinese government has invested billions in biopharmaceutical innovation and infrastructure under initiatives such as the "Healthy China 2030" program and the National Strategic Emerging Industries Plan. By encouraging the development of sophisticated filtration technologies by both public and commercial businesses, such as membrane systems that can retain viruses, nanofiltration for protein separation, and high-throughput sterile filters for continuous manufacturing platforms, this assistance promotes innovation. A number of Chinese businesses are becoming pioneers on a global scale. Businesses like Cobetter Filtration, Trueline, and Hangzhou Anow Microfiltration have created unique membrane materials and cartridge technologies catered to the demands of the Chinese pharmaceutical industry, such as heat-stable and high-flow-rate filters for thick TCM extracts. In its manufacturing and testing workflows, which serve both domestic and foreign customers, Wuxi AppTec, a major player in the biopharma services industry, uses cutting-edge filtration technologies. The National Medical Products Administration (NMPA) is responsible for regulatory supervision. Filters used in pharmaceutical applications must meet Chinese Pharmacopoeia standards as well as GMP requirements. Integrity testing (e.g., bubble point, diffusion), microbial retention validation, extractables/leachables evaluations, and cleanroom manufacturing certification are all part of the testing requirements. As Chinese-made medicines increasingly target export markets regulated by EMA and FDA standards, compliance guarantees product safety and global compatibility.

What's Inside a Actual Market Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

The diversity of products has been crucial in meeting the complex demands of both modern biopharmaceuticals and traditional medicine production in China's vibrant pharmaceutical filtration market. Because of their superior retention efficiency against bacteria and small particles, membrane filters remain the cornerstone, especially in sterile filtration. They are frequently utilized in the last fill-finish step for injectables as well as in the creation of monoclonal antibodies and vaccines. In the upstream process of cleaning thick liquids like herbal extracts used in Traditional Chinese Medicines (TCMs), prefilters and depth media are essential. These filters are vital for preventing downstream sterile filters from clogging, which increases cost-effectiveness and extends operational life because of their excellent dirt-holding capacity. The Chinese market is seeing a quick adoption of single-use systems, mostly because of their compatibility with continuous manufacturing operations and their lower risk of cross-contamination. These systems, which include tube assemblies and capsule filters, are frequently employed in contract development and manufacturing companies (CDMOs) such as Wuxi Biologics, which serve both the local and international markets. From buffer and media preparation to solvent filtration, cartridges and capsules meet a variety of needs. They are offered in a wide range of materials and designs to accommodate diverse chemical compatibilities, providing versatility throughout many unit operations. Although less apparent, filter holders are essential components that guarantee the correct lodging and integrity of filter membranes in both batch and continuous systems. Their design must adhere to the pressure, temperature, and chemical resistance criteria mandated by Chinese GMP regulations. In terms of connectors, integrity testers, and sterilization equipment, other filtration accessories are also undergoing local innovation. One of the most widely used techniques is microfiltration, which is mostly employed in the manufacture of injectable drugs for the removal of bacteria and particulates. Chinese enterprises have made significant progress in creating microfiltration membranes that function well in humid and fluctuating temperature conditions, which are essential for ubiquitous regional manufacturing settings. The usage of ultrafiltration has significantly increased, particularly in the biological production industry, where it is used to concentrate proteins and get rid of endotoxins. Maintaining product integrity and minimizing bioburden are particularly important in the manufacture of monoclonal antibodies and recombinant proteins. High-performance ultrafiltration modules designed specifically for single-use systems are now available from local manufacturers such as Trueline and Cobetter. Due to its applicability in big biopharma facilities, particularly in viral filtration and cell harvesting, cross flow filtration (also known as tangential flow filtration) has gained widespread use. It permits continuous filtration, which is perfect for Chinese contract manufacturing firms (CMOs) that handle massive volumes in short timeframes. The cross-flow system's design efficiency aids in reducing membrane fouling, which is very beneficial for TCM formulations with a lot of particulate matter. In contrast to Western markets, where nanofiltration is still quite new in China, it is becoming more and more popular for the purpose of separating out smaller biomolecules, such peptides, and for removing pyrogens. Its capacity to filter at the molecular level makes it a crucial enabler in high-purity applications like mRNA vaccine production and gene therapy. In terms of depth filtration, electropositive filtration, and virus removal filtration, other methods are becoming more popular. These methods are frequently coupled with core filtration strategies to produce multi-stage purification processes that improve product safety, quality, and output. The distinction between sterile and non-sterile filtration types is essential to quality assurance and regulatory compliance in China's fast developing pharmaceutical filtration industry, which encompasses a wide range of medicine manufacturing processes. The foundation of vaccines, biologicals, and parenteral medicines, where final product sterility is not only anticipated but required, is sterile filtration. The membrane filters used in this category must adhere to stringent validation procedures, which include integrity checks such as bubble point and pressure decay, as well as bacterial retention tests. The integration of sterile filtering with automated fill-finish lines in China is growing, which lowers human intervention and guarantees adherence to the National Medical Products Administration (NMPA) and China GMP standards. The rise in sterile filter demand is a result of the growth of biologics and biosimilar manufacture by companies like Sinovac and Wuxi Biologics. To prevent cross-contamination and shorten downtime, these facilities make extensive use of single-use sterile filter assemblies. Traditional Chinese Medicines (TCMs) are becoming injectable, therefore sterile filtration is now being used to herbal injectables. This introduces difficulties due to viscosity and particulates, which Chinese producers are addressing with cutting-edge depth prefiltration and hybrid systems. In contrast, in upstream and auxiliary operations like media preparation, water treatment, and solvent filtration, non-sterile filtration continues to be essential. In general, these filters place more emphasis on particle retention, chemical compatibility, and high throughput than on microbial safety. They are widely utilized in TCM extraction processes, API synthesis, and oral solid dosage (OSD) production.

Make this report your own

We're excited to discuss your needs and our solutions. Let's schedule a call.

Ask an Expert

Nikita Jabrela

Business Development Manager

Considered in this report • Historic Year: 2019 • Base year: 2024 • Estimated year: 2025 • Forecast year: 2030 Aspects covered in this report • Pharmaceutical Filtration Market with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation By Product • Membrane Filters • Prefilters & Depth Media • Single-use Systems • Cartridges & Capsules • Filter Holders • Filtration Accessories • Others

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

By Technique • Microfiltration • Ultrafiltration • Cross Flow Filtration • Nanofiltration • Others By Filteration Type • Sterile • Non-sterile The approach of the report: This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual report of companies, analyzing the government generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources. Intended audience This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to this industry, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.